Comparative/JJ
analysis/NN
identifies/VBZ
conserved/VBN
tumor/NN
necrosis/NN
factor/NN
receptor-associated/JJ
factor/NN
3/CD
binding/NN
sites/NNS
in/IN
the/DT
human/JJ
and/CC
simian/JJ
Epstein-Barr/JJ
virus/NN
oncogene/NN
LMP1/NN
./.

Nonhuman/JJ
primates/NNS
are/VBP
naturally/RB
infected/VBN
with/IN
a/DT
B-lymphotropic/JJ
herpesvirus/NN
closely/RB
related/JJ
to/TO
Epstein-Barr/JJ
virus/NN
(/(
EBV/NN
)/)
./.
=====
These/DT
simian/JJ
EBV/NNS
share/VBP
considerable/JJ
genetic/JJ
,/,
biologic/JJ
,/,
and/CC
epidemiologic/JJ
features/NNS
with/IN
human/JJ
EBV/NN
,/,
including/VBG
virus-induced/JJ
tumorigenesis/NN
./.
=====
However/RB
,/,
latent/JJ
,/,
transformation-associated/JJ
viral/JJ
genes/NNS
demonstrate/VBP
marked/JJ
sequence/NN
divergence/NN
among/IN
species/NNS
despite/IN
the/DT
conserved/VBN
functions/NNS
./.
=====
We/PRP
have/VBP
cloned/VBN
the/DT
latent/JJ
membrane/NN
protein/NN
1/CD
(/(
LMP1/NN
)/)
homologs/NNS
from/IN
the/DT
simian/JJ
EBV/NN
naturally/RB
infecting/VBG
baboons/NNS
(/(
cercopithicine/NN
herpesvirus/NN
12/CD
,/,
herpesvirus/NN
papio/NN
)/)
and/CC
rhesus/NN
monkeys/NNS
(/(
cercopithicine/NN
herpesvirus/NN
15/CD
)/)
for/IN
a/DT
comparative/JJ
study/NN
with/IN
the/DT
human/JJ
EBV/NN
oncogene/NN
./.
=====
The/DT
transmembrane/NN
domains/NNS
are/VBP
well/RB
conserved/VBN
,/,
but/CC
there/EX
is/VBZ
striking/JJ
sequence/NN
divergence/NN
of/IN
the/DT
carboxy-terminal/JJ
cytoplasmic/JJ
domain/NN
essential/JJ
for/IN
B-cell/NN
immortalization/NN
and/CC
interaction/NN
with/IN
the/DT
tumor/NN
necrosis/NN
factor/NN
receptor/NN
signaling/NN
pathway/NN
./.
=====
Nevertheless/RB
,/,
the/DT
simian/JJ
EBV/NN
LMP1s/NNS
retain/VBP
most/JJS
functions/NNS
in/IN
common/NN
with/IN
EBV/NN
LMP1/NN
,/,
including/VBG
the/DT
ability/NN
to/TO
induce/VB
NF-(kappa)B/NN
activity/NN
in/IN
human/JJ
cells/NNS
,/,
to/TO
bind/VB
the/DT
tumor/NN
necrosis/NN
factor-associated/JJ
factor/NN
3/CD
(/(
TRAF3/NN
)/)
in/FW
vitro/FW
,/,
and/CC
to/TO
induce/VB
expression/NN
of/IN
tumor/NN
necrosis/NN
factor-responsive/JJ
genes/NNS
,/,
such/JJ
as/IN
ICAM1/NN
,/,
in/IN
human/JJ
B/NN
lymphocytes/NNS
./.
=====
Multiple/JJ
TRAF3/NN
binding/NN
sites/NNS
containing/VBG
a/DT
PXQXT/S/NN
core/NN
sequence/NN
can/MD
be/VB
identified/VBN
in/IN
the/DT
simian/JJ
EBV/NN
LMP1s/NNS
by/IN
an/DT
in/FW
vitro/FW
binding/NN
assay/NN
./.
=====
A/DT
PXQXT/S-containing/JJ
sequence/NN
is/VBZ
also/RB
present/JJ
in/IN
the/DT
cytoplasmic/JJ
domain/NN
of/IN
the/DT
Hodgkin/NN
's/POS
disease/NN
marker/NN
,/,
CD30/NN
,/,
and/CC
binds/VBZ
TRAF3/NN
in/FW
vitro/FW
./.
=====
The/DT
last/JJ
13/CD
amino/NN
acids/NNS
containing/VBG
a/DT
PXQXT/S/NN
sequence/NN
are/VBP
highly/RB
conserved/VBN
in/IN
human/JJ
and/CC
simian/JJ
EBV/NN
LMP1/NN
but/CC
do/VBP
not/RB
bind/VB
TRAF3/NN
,/,
suggesting/VBG
a/DT
distinct/JJ
role/NN
for/IN
this/DT
conserved/VBN
region/NN
of/IN
LMP1/NN
./.
=====
The/DT
conserved/VBN
TRAF3/NN
binding/NN
sites/NNS
in/IN
LMP1/NN
and/CC
the/DT
CD30/NN
Hodgkin/NN
's/POS
disease/NN
marker/NN
provides/VBZ
further/JJ
evidence/NN
that/IN
a/DT
TRAF3-mediated/JJ
signal/NN
transduction/NN
pathway/NN
may/MD
be/VB
important/JJ
in/IN
malignant/JJ
transformation/NN
./.